Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy.

Medicine (Baltimore) · 2016 · PMC4985293 · PMID 27512838

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.1790

boldest claim

The sentences

borderline significantP = 0.06so close (0.05 < p ≤ 0.1)

RNI was also associated with a borderline significant reduction of LRR (3-year LRR rate 4.2% vs 8.1%, P = 0.06).

also in 11,409 other papers

did not reach statistical significanceP = 0.179not close (p > 0.1)

However, the difference did not reach statistical significance ( P = 0.179) (Fig. 1 C). 3.4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.